{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:18:36Z","timestamp":1776406716980,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.gassur.2024.04.030","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T16:30:08Z","timestamp":1714753808000},"page":"1095-1103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Perioperative intraperitoneal plus systemic chemotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gastric cancer: phase Ib\/II single-arm prospective study"],"prefix":"10.1016","volume":"28","author":[{"given":"Minah","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Song","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minkyu","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8593-9214","authenticated-orcid":false,"given":"Woo Jin","family":"Hyung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.gassur.2024.04.030_bib1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1245\/s10434-016-5645-x","article-title":"Race is a risk for lymph node metastasis in patients with gastric cancer","volume":"24","author":"Ikoma","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.030_bib2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.030_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/JCO.1997.15.1.261","article-title":"Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer","volume":"15","author":"Webb","year":"1997","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.030_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.sla.0000197382.43208.a5","article-title":"Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma","volume":"243","author":"Sarela","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.gassur.2024.04.030_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1745-6215-10-121","article-title":"The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone","volume":"10","author":"Kerkar","year":"2009","journal-title":"Trials"},{"issue":"11","key":"10.1016\/j.gassur.2024.04.030_bib6","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00268-012-1721-y","article-title":"Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis","volume":"36","author":"Tokunaga","year":"2012","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.030_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","article-title":"Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial","volume":"17","author":"Fujitani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.030_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5230\/jgc.2019.19.e8","article-title":"Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach","volume":"19","author":"Guideline Committee of the Korean Gastric Cancer Association (KGCA)","year":"2019","journal-title":"J Gastric Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.030_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-020-01042-y","article-title":"Japanese gastric cancer treatment guidelines 2018. 5th ed.","volume":"24","author":"Japanese Gastric Cancer Association","year":"2021","journal-title":"Gastric Cancer"},{"issue":"10","key":"10.1016\/j.gassur.2024.04.030_bib10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.030_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/annonc\/mdy502","article-title":"Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS","volume":"30","author":"Muro","year":"2019","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.030_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer. Version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"23","key":"10.1016\/j.gassur.2024.04.030_bib13","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2024.04.030_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ejso.2015.03.231","article-title":"Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis","volume":"41","author":"Coccolini","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2024.04.030_bib15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ejso.2016.03.016","article-title":"A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent","volume":"42","author":"Yonemura","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.gassur.2024.04.030_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.030_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/bjc.2014.602","article-title":"Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer","volume":"112","author":"Ansaloni","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gassur.2024.04.030_bib18","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/s002800051093","article-title":"Successful management of microscopic residual disease in large bowel cancer","volume":"43","author":"Sugarbaker","year":"1999","journal-title":"Cancer Chemother Pharm"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.030_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.gassur.2024.04.030_bib20","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2024.04.030_bib21","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"10.1016\/j.gassur.2024.04.030_bib22","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","article-title":"Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial","volume":"36","author":"Ishigami","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.030_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1245\/s10434-013-3208-y","article-title":"Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites","volume":"21","author":"Kitayama","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.gassur.2024.04.030_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10120-016-0684-3","article-title":"Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings","volume":"20","author":"Ishigami","year":"2017","journal-title":"Gastric Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.030_bib25","first-page":"45","article-title":"Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy","volume":"7","author":"Goodman","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.030_bib26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1055-3207(03)00038-3","article-title":"Intraperitoneal taxanes","volume":"12","author":"Mohamed","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"10.1016\/j.gassur.2024.04.030_bib27","first-page":"871","article-title":"Determinants of paclitaxel penetration and accumulation in human solid tumor","volume":"290","author":"Kuh","year":"1999","journal-title":"J Pharm Exp Ther"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.030_bib28","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/IGC.0b013e31824d836c","article-title":"Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer","volume":"22","author":"Ansaloni","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.030_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.030_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3802\/jgo.2015.26.1.54","article-title":"Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study","volume":"26","author":"Coccolini","year":"2015","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2024.04.030_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.21037\/jgo.2017.03.11","article-title":"Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis","volume":"8","author":"Fugazzola","year":"2017","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.04.030_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gassur.2024.04.030_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1470-2045(18)30132-3","article-title":"Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial","volume":"19","author":"Cats","year":"2018","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.gassur.2024.04.030_bib34","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.20.02914","article-title":"PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer","volume":"39","author":"Kang","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24004396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24004396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T13:13:12Z","timestamp":1719925992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X24004396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1091255X24004396"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2024.04.030","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative intraperitoneal plus systemic chemotherapy and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gastric cancer: phase Ib\/II single-arm prospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2024.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}